It has been reported that the oxidative phosphorylation CD8+ T cell subset is predictive of immunotherapy resistance in melanoma patients (15), and CD8+ T-cell infiltration could influence patient survival in cutaneous melanoma directly (16). The gene discussed is CD8A; the disease is cutaneous melanoma.